CJC-1295 with DAC and Cyclic Glycine-Proline Interaction
CJC-1295 with DAC and Cyclic Glycine-Proline have an interaction requiring monitoring for interaction with 47% confidence. Both CJC-1295 with DAC and Cyclic Glycine-Proline affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). These compounds primarily affect different organ systems.
Compound Profiles
CJC-1295 with DAC
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..
View full profileCyclic Glycine-Proline
IGF-1 Bioavailability Regulator & Neuroprotective Peptide
Competes with IGF-1 for IGFBP-3 binding, normalizing bioavailable IGF-1 levels. Acts as positive allosteric modulator of AMPA and GABA-A receptors.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 with DAC with Cyclic Glycine-Proline?
Yes, but with caution. Both CJC-1295 with DAC and Cyclic Glycine-Proline affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.
Is CJC-1295 with DAC and Cyclic Glycine-Proline safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting. Monitor accordingly.
What are the interactions between CJC-1295 with DAC and Cyclic Glycine-Proline?
Both CJC-1295 with DAC and Cyclic Glycine-Proline affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.
How should I time CJC-1295 with DAC and Cyclic Glycine-Proline?
CJC-1295 with DAC has a half-life of 6-8 days and Cyclic Glycine-Proline has a half-life of Extended stability (more stable than linear GPE precursor). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.